These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 26875483)

  • 1. Usefulness of Levocarnitine and/or Branched-Chain Amino Acids during Invasive Treatment for Hepatocellular Carcinoma.
    Iwasa M; Sugimoto R; Ishihara T; Sekoguchi-Fujikawa N; Yoshikawa K; Mifuji-Moroka R; Tanaka H; Kobayashi Y; Hasegawa H; Takei Y
    J Nutr Sci Vitaminol (Tokyo); 2015; 61(6):433-40. PubMed ID: 26875483
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of branched-chain amino acids in patients receiving intervention for hepatocellular carcinoma.
    Ishihara T; Iwasa M; Tanaka H; Kaito M; Ikoma J; Shibata T; Takei Y
    World J Gastroenterol; 2014 Mar; 20(10):2673-80. PubMed ID: 24627603
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of branched-chain amino acid supplementation after radiofrequency ablation for hepatocellular carcinoma: A randomized trial.
    Nojiri S; Fujiwara K; Shinkai N; Iio E; Joh T
    Nutrition; 2017 Jan; 33():20-27. PubMed ID: 27908546
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A snack enriched with oral branched-chain amino acids prevents a fall in albumin in patients with liver cirrhosis undergoing chemoembolization for hepatocellular carcinoma.
    Takeshita S; Ichikawa T; Nakao K; Miyaaki H; Shibata H; Matsuzaki T; Muraoka T; Honda T; Otani M; Akiyama M; Miuma S; Ozawa E; Fujimito M; Eguchi K
    Nutr Res; 2009 Feb; 29(2):89-93. PubMed ID: 19285598
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of Oral L-Carnitine on Liver Functions after Transarterial Chemoembolization in Intermediate-Stage HCC Patients.
    Hassan A; Tsuda Y; Asai A; Yokohama K; Nakamura K; Sujishi T; Ohama H; Tsuchimoto Y; Fukunishi S; Abdelaal UM; Arafa UA; Hassan AT; Kassem AM; Higuchi K
    Mediators Inflamm; 2015; 2015():608216. PubMed ID: 26664151
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Importance of branched-chain amino acids in patients with liver cirrhosis and advanced hepatocellular carcinoma receiving hepatic arterial infusion chemotherapy.
    Kanekawa T; Nagai H; Kanayama M; Sumino Y
    Cancer Chemother Pharmacol; 2014 Nov; 74(5):899-909. PubMed ID: 25138286
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Branched-chain amino acid treatment before transcatheter arterial chemoembolization for hepatocellular carcinoma.
    Nishikawa H; Osaki Y; Inuzuka T; Takeda H; Nakajima J; Matsuda F; Henmi S; Sakamoto A; Ishikawa T; Saito S; Kita R; Kimura T
    World J Gastroenterol; 2012 Mar; 18(12):1379-84. PubMed ID: 22493552
    [TBL] [Abstract][Full Text] [Related]  

  • 8. L-Carnitine for the Treatment of Overt Hepatic Encephalopathy in Patients with Advanced Liver Cirrhosis.
    Tajiri K; Futsukaichi Y; Kobayashi S; Yasumura S; Takahara T; Minemura M; Sugiyama T
    J Nutr Sci Vitaminol (Tokyo); 2018; 64(5):321-328. PubMed ID: 30381621
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Branched-chain amino acids prevent hepatocarcinogenesis and prolong survival of patients with cirrhosis.
    Kawaguchi T; Shiraishi K; Ito T; Suzuki K; Koreeda C; Ohtake T; Iwasa M; Tokumoto Y; Endo R; Kawamura NH; Shiraki M; Habu D; Tsuruta S; Miwa Y; Kawaguchi A; Kakuma T; Sakai H; Kawada N; Hanai T; Takahashi S; Kato A; Onji M; Takei Y; Kohgo Y; Seki T; Tamano M; Katayama K; Mine T; Sata M; Moriwaki H; Suzuki K
    Clin Gastroenterol Hepatol; 2014 Jun; 12(6):1012-8.e1. PubMed ID: 24036055
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oral branched-chain amino acids administration improves impaired liver dysfunction after radiofrequency ablation therapy for hepatocellular carcinoma.
    Ishikawa T; Michitaka I; Kamimura H; Higuchi K; Kubota T; Seki K; Ohta H; Yoshida T; Kamimura T
    Hepatogastroenterology; 2009; 56(94-95):1491-5. PubMed ID: 19950815
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of Branched-Chain Amino Acid-Enriched Nutrient on liver Cirrhosis with Hepatocellular Carcinoma Undergoing Transcatheter Arterial Chemoembolization in Barcelona Clinic Liver Cancer Stage B: A Prospective Study.
    Shiozawa S; Usui T; Kuhara K; Tsuchiya A; Miyauchi T; Kono T; Asaka S; Yamaguchi K; Yokomizo H; Shimakawa T; Yoshimatsu K; Katsube T; Naritaka Y
    J Nippon Med Sch; 2016; 83(6):248-256. PubMed ID: 28133005
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oral branched-chain amino acid granules reduce the incidence of hepatocellular carcinoma and improve event-free survival in patients with liver cirrhosis.
    Hayaishi S; Chung H; Kudo M; Ishikawa E; Takita M; Ueda T; Kitai S; Inoue T; Yada N; Hagiwara S; Minami Y; Ueshima K
    Dig Dis; 2011; 29(3):326-32. PubMed ID: 21829025
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Morbidity and mortality following transarterial liver chemoembolization in patients with hepatocellular carcinoma and synthetic hepatic dysfunction.
    Garwood ER; Fidelman N; Hoch SE; Kerlan RK; Yao FY
    Liver Transpl; 2013 Feb; 19(2):164-73. PubMed ID: 23008091
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Supplementation of branched-chain amino acids maintains the serum albumin level in the course of hepatocellular carcinoma recurrence.
    Kakazu E; Kondo Y; Kogure T; Ninomiya M; Kimura O; Iwata T; Morosawa T; Iwasaki T; Shimosegawa T
    Tohoku J Exp Med; 2013 Aug; 230(4):191-6. PubMed ID: 23892757
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Branched-chain amino acids and l-carnitine attenuate lipotoxic hepatocellular damage in rat cirrhotic liver.
    Tamai Y; Chen Z; Wu Y; Okabe J; Kobayashi Y; Chiba H; Hui SP; Eguchi A; Iwasa M; Ito M; Takei Y
    Biomed Pharmacother; 2021 Mar; 135():111181. PubMed ID: 33395607
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of long-term supplementation with branched-chain amino acid granules in patients with hepatitis C virus-related hepatocellular carcinoma after radiofrequency thermal ablation.
    Nishikawa H; Osaki Y; Iguchi E; Koshikawa Y; Ako S; Inuzuka T; Takeda H; Nakajima J; Matsuda F; Sakamoto A; Henmi S; Hatamaru K; Ishikawa T; Saito S; Nasu A; Kita R; Kimura T
    J Clin Gastroenterol; 2013 Apr; 47(4):359-66. PubMed ID: 23090049
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Branched chain amino acids supplemented with L-acetylcarnitine versus BCAA treatment in hepatic coma: a randomized and controlled double blind study.
    Malaguarnera M; Risino C; Cammalleri L; Malaguarnera L; Astuto M; Vecchio I; Rampello L
    Eur J Gastroenterol Hepatol; 2009 Jul; 21(7):762-70. PubMed ID: 19357525
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Branched-chain amino acid granules improve the non-protein respiratory quotient after radiofrequency ablation.
    Saito M; Yano Y; Minami A; Hirano H; Momose K; Sugimoto M; Yoshida M; Azuma T
    Intern Med; 2014; 53(14):1469-75. PubMed ID: 25030556
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Comparison of safety and efficacy for transcatheter arterial chemoembolization alone and plus radiofrequency ablation in the treatment of single branch portal vein tumor thrombus of hepatocellular carcinoma and their prognosis factors].
    Zhao M; Wang JP; Li W; Huang ZL; Zhang FJ; Fan WJ; Zhang L; Li XS; Pan CC; Wu PH
    Zhonghua Yi Xue Za Zhi; 2011 May; 91(17):1167-72. PubMed ID: 21756768
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of the branched-chain amino acid to tyrosine ratio and branched-chain amino acid granule therapy in patients with hepatocellular carcinoma: A propensity score analysis.
    Tada T; Kumada T; Toyoda H; Kiriyama S; Tanikawa M; Hisanaga Y; Kanamori A; Kitabatake S; Yama T
    J Gastroenterol Hepatol; 2015 Sep; 30(9):1412-9. PubMed ID: 25799910
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.